These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1425971)

  • 1. Memantine prevents quinolinic acid-induced hippocampal damage.
    Keilhoff G; Wolf G
    Eur J Pharmacol; 1992 Sep; 219(3):451-4. PubMed ID: 1425971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Memantine Is Protective against Cytotoxicity Caused by Lead and Quinolinic Acid in Cultured Rat Embryonic Hippocampal Cells.
    Rahman A; Al-Qenaie S; Rao MS; Khan KM; Guillemin GJ
    Chem Res Toxicol; 2019 Jun; 32(6):1134-1143. PubMed ID: 30950269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive dysfunction induced by sequential injection of amyloid-beta and ibotenate into the bilateral hippocampus; protection by memantine and MK-801.
    Nakamura S; Murayama N; Noshita T; Katsuragi R; Ohno T
    Eur J Pharmacol; 2006 Oct; 548(1-3):115-22. PubMed ID: 16952349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin plays a protective role in quinolinic acid-induced neurotoxicity in the rat hippocampus.
    Southgate GS; Daya S; Potgieter B
    J Chem Neuroanat; 1998 Jun; 14(3-4):151-6. PubMed ID: 9704893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Learning deficits induced by chronic intraventricular infusion of quinolinic acid--protection by MK-801 and memantine.
    Misztal M; Frankiewicz T; Parsons CG; Danysz W
    Eur J Pharmacol; 1996 Jan; 296(1):1-8. PubMed ID: 8720470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketamine, but not glycine modulates quinolinate-induced neurodegeneration.
    Henschke G; Wolf G; Keilhoff G
    Pol J Pharmacol; 1993; 45(4):339-47. PubMed ID: 8118480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NMDA preconditioning protects against seizures and hippocampal neurotoxicity induced by quinolinic acid in mice.
    Boeck CR; Ganzella M; Lottermann A; Vendite D
    Epilepsia; 2004 Jul; 45(7):745-50. PubMed ID: 15230696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneously applied magnesium protects reliably against quinolinate-induced N-methyl-D-aspartate (NMDA)-mediated neurodegeneration and convulsions in rats: are there therapeutical implications.
    Wolf G; Keilhoff G; Fischer S; Hass P
    Neurosci Lett; 1990 Sep; 117(1-2):207-11. PubMed ID: 2149747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress as a mechanism for quinolinic acid-induced hippocampal damage: protection by melatonin and deprenyl.
    Behan WM; McDonald M; Darlington LG; Stone TW
    Br J Pharmacol; 1999 Dec; 128(8):1754-60. PubMed ID: 10588931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3-Nitropropionic acid toxicity in hippocampus: protection through N-methyl-D-aspartate receptor antagonism.
    Karanian DA; Baude AS; Brown QB; Parsons CG; Bahr BA
    Hippocampus; 2006; 16(10):834-42. PubMed ID: 16897723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective properties of memantine in different in vitro and in vivo models of excitotoxicity.
    Volbracht C; van Beek J; Zhu C; Blomgren K; Leist M
    Eur J Neurosci; 2006 May; 23(10):2611-22. PubMed ID: 16817864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered glutamate binding following quinolinate lesions in developing rat brain.
    Lisý V; Dvoráková L; Stastný F
    Exp Neurol; 1994 Jan; 125(1):82-6. PubMed ID: 7905837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid.
    Harris CA; Miranda AF; Tanguay JJ; Boegman RJ; Beninger RJ; Jhamandas K
    Br J Pharmacol; 1998 May; 124(2):391-9. PubMed ID: 9641558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quinolinate potentiates the neurotoxicity of excitatory amino acids in hypoxic neuronal tissue in vitro.
    Schurr A; Rigor BM
    Brain Res; 1993 Jul; 617(1):76-80. PubMed ID: 8397046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential neuronal vulnerability to amino-oxyacetate and quinolinate in the rat parahippocampal region.
    Eid T; Du F; Schwarcz R
    Neuroscience; 1995 Oct; 68(3):645-56. PubMed ID: 8577365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excessive Activation of NMDA Receptors Induced Neurodevelopmental Brain Damage and Cognitive Deficits in Rats Exposed to Intrauterine Hypoxia.
    Li T; Luo Z; Liu Y; Wang M; Yu X; Cao C; Liao Z; Ding Y; Yue S
    Neurochem Res; 2018 Mar; 43(3):566-580. PubMed ID: 29260492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 17Beta-estradiol attenuates quinolinic acid insult in the rat hippocampus.
    Heron P; Daya S
    Metab Brain Dis; 2001 Dec; 16(3-4):187-98. PubMed ID: 11769331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of memantine, an N-methyl-D-aspartate receptor antagonist, on fatigue and neuronal brain damage in a rat model of combined (physical and mental) fatigue.
    Morimoto Y; Zhang Q; Adachi K
    Biol Pharm Bull; 2012; 35(4):481-6. PubMed ID: 22466550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Withdrawal from Extended, Intermittent Access to A Highly Palatable Diet Impairs Hippocampal Memory Function and Neurogenesis: Effects of Memantine.
    Ferragud A; Velázquez-Sánchez C; Abdullatif AA; Sabino V; Cottone P
    Nutrients; 2020 May; 12(5):. PubMed ID: 32456193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible mediation of quinolinic acid-induced hippocampal damage by reactive oxygen species.
    Stone TW; Behan WM; MacDonald M; Darlington LG
    Amino Acids; 2000; 19(1):275-81. PubMed ID: 11026499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.